Lundbeck Investor

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
Technology: Neurological
Industry: Healthcare
Headquarters: Copenhagen, Denmark
Founded Date: 2000
Employees Number: 5001-10000
Funding Status: IPO
Investor Type: Undisclosed
Investment Stage: N/A
Number Of Exits: 1

Visit Website
information@lundbeck.com
@LumiaCapital
Register and Claim Ownership